{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T05:06:43Z","timestamp":1794978403698,"version":"4.9.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-027406, INV-041469"],"award-info":[{"award-number":["INV-027406, INV-041469"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA260476"],"award-info":[{"award-number":["CA260476"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Long COVID (LC) involves a spectrum of chronic symptoms after acute severe acute respiratory syndrome coronavirus 2 infection. Current hypotheses for the pathogenesis of LC include persistent virus, tissue damage, autoimmunity, endocrine insufficiency, immune dysfunction and complement activation. We performed immunological, virological, transcriptomic and proteomic analyses from a cohort of 142 individuals between 2020 and 2021, including uninfected controls (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200935), acutely infected individuals (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200954), convalescent controls (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200924) and patients with LC (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200928). The LC group was characterized by persistent immune activation and proinflammatory responses for more than 180 days after initial infection compared with convalescent controls, including upregulation of JAK-STAT, interleukin-6, complement, metabolism and T cell exhaustion pathways. Similar findings were observed in a second cohort enrolled between 2023 and 2024, including convalescent controls (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200920) and patients with LC (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200918). These data suggest that LC is characterized by persistent activation of chronic inflammatory pathways, suggesting new therapeutic targets and potential biomarkers of disease.\n                  <\/jats:p>","DOI":"10.1038\/s41590-025-02353-x","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T10:02:25Z","timestamp":1765533745000},"page":"61-71","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Long COVID involves activation of proinflammatory and immune exhaustion pathways"],"prefix":"10.1038","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4498-7893","authenticated-orcid":false,"given":"Malika","family":"Aid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Boero-Teyssier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"McMahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4014-6429","authenticated-orcid":false,"given":"Rammy","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazim","family":"Belabbaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Borducchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8539-3960","authenticated-orcid":false,"given":"Ai-ris Y.","family":"Collier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9156-9424","authenticated-orcid":false,"given":"Janet","family":"Mullington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5127-4659","authenticated-orcid":false,"given":"Dan H.","family":"Barouch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"2353_CR1","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1159\/000535736","volume":"185","author":"E Untersmayr","year":"2024","unstructured":"Untersmayr, E. et al. Immune mechanisms underpinning long COVID: Collegium Internationale Allergologicum Update 2024. Int. Arch. Allergy Immunol. 185, 489\u2013502 (2024).","journal-title":"Int. Arch. Allergy Immunol."},{"key":"2353_CR2","unstructured":"National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Global Health; Board on Health Sciences Policy; Committee on Examining the Working Definition for Long COVID. A Long COVID Definition: A Chronic, Systemic Disease State with Profound Consequences (eds. Goldowitz, I. et al.) (National Academies Press, 2024)."},{"key":"2353_CR3","doi-asserted-by":"publisher","first-page":"698169","DOI":"10.3389\/fmicb.2021.698169","volume":"12","author":"AD Proal","year":"2021","unstructured":"Proal, A. D. & VanElzakker, M. B. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front. Microbiol. 12, 698169 (2021).","journal-title":"Front. Microbiol."},{"key":"2353_CR4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","volume":"21","author":"HE Davis","year":"2023","unstructured":"Davis, H. E., McCorkell, L., Vogel, J. M. & Topol, E. J. Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 21, 133\u2013146 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"2353_CR5","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/s41392-023-01640-z","volume":"8","author":"J Li","year":"2023","unstructured":"Li, J. et al. The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID. Signal Transduct. Target. Ther. 8, 416 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2353_CR6","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.cell.2022.01.014","volume":"185","author":"Y Su","year":"2022","unstructured":"Su, Y. et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell 185, 881\u2013895 (2022).","journal-title":"Cell"},{"key":"2353_CR7","doi-asserted-by":"publisher","first-page":"5500","DOI":"10.1016\/j.cell.2024.07.054","volume":"187","author":"MJ Peluso","year":"2024","unstructured":"Peluso, M. J. & Deeks, S. G. Mechanisms of long COVID and the path toward therapeutics. Cell 187, 5500\u20135529 (2024).","journal-title":"Cell"},{"key":"2353_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.105717","volume":"26","author":"JJ Kovarik","year":"2023","unstructured":"Kovarik, J. J. et al. A multi-omics based anti-inflammatory immune signature characterizes long COVID-19 syndrome. iScience 26, 105717 (2023).","journal-title":"iScience"},{"key":"2353_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-021-01130-1","volume":"21","author":"N Moghimi","year":"2021","unstructured":"Moghimi, N. et al. The neurological manifestations of post-acute sequelae of SARS-CoV-2 infection. Curr. Neurol. Neurosci. Rep. 21, 44 (2021).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"2353_CR10","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1016\/j.cell.2023.09.013","volume":"186","author":"AC Wong","year":"2023","unstructured":"Wong, A. C. et al. Serotonin reduction in post-acute sequelae of viral infection. Cell 186, 4851\u20134867 (2023).","journal-title":"Cell"},{"key":"2353_CR11","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S1473-3099(23)00053-1","volume":"23","author":"A Iwasaki","year":"2023","unstructured":"Iwasaki, A. & Putrino, D. Why we need a deeper understanding of the pathophysiology of long COVID. Lancet Infect. Dis. 23, 393\u2013395 (2023).","journal-title":"Lancet Infect. Dis."},{"key":"2353_CR12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41586-023-06651-y","volume":"623","author":"J Klein","year":"2023","unstructured":"Klein, J. et al. Distinguishing features of long COVID identified through immune profiling. Nature 623, 139\u2013148 (2023).","journal-title":"Nature"},{"key":"2353_CR13","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.it.2022.02.008","volume":"43","author":"MJ Peluso","year":"2022","unstructured":"Peluso, M. J. & Deeks, S. G. Early clues regarding the pathogenesis of long-COVID. Trends Immunol. 43, 268\u2013270 (2022).","journal-title":"Trends Immunol."},{"key":"2353_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100663","volume":"3","author":"C Schulthei\u00df","year":"2022","unstructured":"Schulthei\u00df, C. et al. The IL-1\u03b2, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep. Med. 3, 100663 (2022).","journal-title":"Cell Rep. Med."},{"key":"2353_CR15","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41590-023-01724-6","volume":"25","author":"K Yin","year":"2024","unstructured":"Yin, K. et al. Long COVID manifests with T cell dysregulation, inflammation, and an uncoordinated adaptive immune response to SARS-CoV-2. Nat. Immunol. 25, 218\u2013225 (2024).","journal-title":"Nat. Immunol."},{"key":"2353_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109518","volume":"36","author":"MJ Peluso","year":"2021","unstructured":"Peluso, M. J. et al. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Cell Rep. 36, 109518 (2021).","journal-title":"Cell Rep."},{"key":"2353_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-021-01359-7","volume":"20","author":"E Pretorius","year":"2021","unstructured":"Pretorius, E. et al. Persistent clotting protein pathology in LongCOVID\/Post\u2011Acute Sequelae of COVID\u201119 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc. Diabetol. 20, 172 (2021).","journal-title":"Cardiovasc. Diabetol."},{"key":"2353_CR18","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12933-022-01623-4","volume":"21","author":"A Kruger","year":"2022","unstructured":"Kruger, A. et al. Post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system. Cardiovasc. Diabetol. 21, 190 (2022).","journal-title":"Cardiovasc. Diabetol."},{"key":"2353_CR19","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.3390\/metabo12111026","volume":"12","author":"VP Guntur","year":"2022","unstructured":"Guntur, V. P. et al. Signatures of mitochondrial dysfunction and impaired fatty acid metabolism in plasma of patients with post-acute sequelae of COVID-19 (PASC). Metabolites 12, 1026 (2022).","journal-title":"Metabolites"},{"key":"2353_CR20","doi-asserted-by":"publisher","first-page":"e487","DOI":"10.1093\/cid\/ciac722","volume":"76","author":"Z Swank","year":"2023","unstructured":"Swank, Z. et al. Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae. Clin. Infect. Dis. 76, e487\u2013e490 (2023).","journal-title":"Clin. Infect. Dis."},{"key":"2353_CR21","doi-asserted-by":"publisher","first-page":"e345","DOI":"10.1016\/S1473-3099(24)00211-1","volume":"24","author":"MJ Peluso","year":"2024","unstructured":"Peluso, M. J. et al. Plasma-based antigen persistence in the post-acute phase of COVID-19. Lancet Infect. Dis. 24, e345\u2013e347 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"2353_CR22","doi-asserted-by":"publisher","unstructured":"Foo, S. S. et al. Immunometabolic rewiring in long COVID patients with chronic headache. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2023.03.06.531302 (2023).","DOI":"10.1101\/2023.03.06.531302"},{"key":"2353_CR23","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41591-022-02107-4","volume":"29","author":"RC Thompson","year":"2023","unstructured":"Thompson, R. C. et al. Molecular states during acute COVID-19 reveal distinct etiologies of long-term sequelae. Nat. Med. 29, 236\u2013246 (2023).","journal-title":"Nat. Med."},{"key":"2353_CR24","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3389\/fimmu.2019.00527","volume":"10","author":"FJ Duffy","year":"2019","unstructured":"Duffy, F. J. et al. Immunometabolic signatures predict risk of progression to active tuberculosis and disease outcome. Front. Immunol. 10, 527 (2019).","journal-title":"Front. Immunol."},{"key":"2353_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinpr.2023.100232","volume":"19","author":"D Moynan","year":"2023","unstructured":"Moynan, D. et al. The reactivation of herpesviruses in severe COVID-19; a retrospective analysis of a critical care cohort. Clin. Infect. Pr. 19, 100232 (2023).","journal-title":"Clin. Infect. Pr."},{"key":"2353_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-39049-x","volume":"13","author":"Y L\u00f3pez-Hern\u00e1ndez","year":"2023","unstructured":"L\u00f3pez-Hern\u00e1ndez, Y. et al. The plasma metabolome of long COVID patients two years after infection. Sci. Rep. 13, 12420 (2023).","journal-title":"Sci. Rep."},{"key":"2353_CR27","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s10787-023-01188-y","volume":"31","author":"I Muzyka","year":"2023","unstructured":"Muzyka, I. et al. What is the role of brown adipose tissue in metabolic health: lessons learned and future perspectives in the long COVID? Inflammopharmacology 31, 585\u2013595 (2023).","journal-title":"Inflammopharmacology"},{"key":"2353_CR28","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41590-023-01724-6","volume":"25","author":"K Yin","year":"2024","unstructured":"Yin, K. et al. Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2. Nat. Immunol. 25, 218\u2013225 (2024).","journal-title":"Nat. Immunol."},{"key":"2353_CR29","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1182\/bloodadvances.2020003568","volume":"5","author":"ML Meizlish","year":"2021","unstructured":"Meizlish, M. L. et al. A neutrophil activation signature predicts critical illness and mortality in COVID-19. Blood Adv. 5, 1164\u20131177 (2021).","journal-title":"Blood Adv."},{"key":"2353_CR30","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s10020-023-00610-z","volume":"29","author":"MA Patel","year":"2023","unstructured":"Patel, M. A. et al. Organ and cell-specific biomarkers of Long-COVID identified with targeted proteomics and machine learning. Mol. Med. 29, 26 (2023).","journal-title":"Mol. Med."},{"key":"2353_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.746021","volume":"12","author":"BK Patterson","year":"2021","unstructured":"Patterson, B. K. et al. Persistence of SARS CoV-2 S1 protein in CD16+ monocytes in post-acute sequelae of COVID-19 (PASC) up to 15 months post-infection. Front. Immunol. 12, 746021 (2021).","journal-title":"Front. Immunol."},{"key":"2353_CR32","doi-asserted-by":"publisher","DOI":"10.1126\/science.adg7942","volume":"383","author":"C Cervia-Hasler","year":"2024","unstructured":"Cervia-Hasler, C. et al. Persistent complement dysregulation with signs of thromboinflammation in active Long Covid. Science 383, eadg7942 (2024).","journal-title":"Science"},{"key":"2353_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38682-4","volume":"14","author":"A Talla","year":"2023","unstructured":"Talla, A. et al. Persistent serum protein signatures define an inflammatory subcategory of long COVID. Nat. Commun. 14, 3417 (2023).","journal-title":"Nat. Commun."},{"key":"2353_CR34","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1001\/jamainternmed.2024.2007","volume":"184","author":"LN Geng","year":"2024","unstructured":"Geng, L. N. et al. Nirmatrelvir-ritonavir and symptoms in adults with postacute sequelae of SARS-CoV-2 infection: the STOP-PASC randomized clinical trial. JAMA Intern. Med. 184, 1024\u20131034 (2024).","journal-title":"JAMA Intern. Med."},{"key":"2353_CR35","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3390\/brainsci11030305","volume":"11","author":"M Ciaccio","year":"2021","unstructured":"Ciaccio, M. et al. COVID-19 and Alzheimer\u2019s disease. Brain Sci. 11, 305 (2021).","journal-title":"Brain Sci."},{"key":"2353_CR36","doi-asserted-by":"publisher","first-page":"4193","DOI":"10.1093\/brain\/awac270","volume":"145","author":"AL Soung","year":"2022","unstructured":"Soung, A. L. et al. COVID-19 induces CNS cytokine expression and loss of hippocampal neurogenesis. Brain 145, 4193\u20134201 (2022).","journal-title":"Brain"},{"key":"2353_CR37","doi-asserted-by":"publisher","first-page":"e200097","DOI":"10.1212\/NXI.0000000000200097","volume":"10","author":"Y Mina","year":"2023","unstructured":"Mina, Y. et al. Deep phenotyping of neurologic postacute sequelae of SARS-CoV-2 infection. Neurol. Neuroimmunol. Neuroinflamm. 10, e200097 (2023).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"2353_CR38","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1590\/1516-4446-2020-1488","volume":"43","author":"JS Generoso","year":"2021","unstructured":"Generoso, J. S. et al. Neurobiology of COVID-19: how can the virus affect the brain? Braz. J. Psychiatry 43, 650\u2013664 (2021).","journal-title":"Braz. J. Psychiatry"},{"key":"2353_CR39","doi-asserted-by":"publisher","first-page":"100399","DOI":"10.1016\/j.bbih.2021.100399","volume":"19","author":"F Sarubbo","year":"2022","unstructured":"Sarubbo, F., El Haji, K., Vidal-Balle, A. & Bargay Lleonart, J. Neurological consequences of COVID-19 and brain related pathogenic mechanisms: a new challenge for neuroscience. Brain Behav. Immun. Health 19, 100399 (2022).","journal-title":"Brain Behav. Immun. Health"},{"key":"2353_CR40","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1007\/s44197-023-00146-9","volume":"13","author":"HM Adly","year":"2023","unstructured":"Adly, H. M. et al. Post COVID-19 symptoms among infected vaccinated individuals: a cross-sectional study in Saudi Arabia. J. Epidemiol. Glob. Health 13, 740\u2013750 (2023).","journal-title":"J. Epidemiol. Glob. Health"},{"key":"2353_CR41","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1001\/jama.2023.8823","volume":"329","author":"T Thaweethai","year":"2023","unstructured":"Thaweethai, T. et al. Development of a definition of postacute sequelae of SARS-CoV-2 infection. JAMA 329, 1934\u20131946 (2023).","journal-title":"JAMA"},{"key":"2353_CR42","doi-asserted-by":"publisher","first-page":"762315","DOI":"10.3389\/fimmu.2021.762315","volume":"12","author":"K Borah","year":"2021","unstructured":"Borah, K., Xu, Y. & McFadden, J. Dissecting host-pathogen interactions in TB using systems-based omic approaches. Front. Immunol. 12, 762315 (2021).","journal-title":"Front. Immunol."},{"key":"2353_CR43","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41590-021-01113-x","volume":"23","author":"C Phetsouphanh","year":"2022","unstructured":"Phetsouphanh, C. et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 23, 210\u2013216 (2022).","journal-title":"Nat. Immunol."},{"key":"2353_CR44","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41590-024-01778-0","volume":"25","author":"F Liew","year":"2024","unstructured":"Liew, F. et al. Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease. Nat. Immunol. 25, 607\u2013621 (2024).","journal-title":"Nat. Immunol."},{"key":"2353_CR45","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41556-022-00842-x","volume":"24","author":"F Rossiello","year":"2022","unstructured":"Rossiello, F., Jurk, D., Passos, J. F. & d\u2019Adda di Fagagna, F. Telomere dysfunction in ageing and age-related diseases. Nat. Cell Biol. 24, 135\u2013147 (2022).","journal-title":"Nat. Cell Biol."},{"key":"2353_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1708","volume":"3","author":"G Hewitt","year":"2012","unstructured":"Hewitt, G. et al. Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence. Nat. Commun. 3, 708 (2012).","journal-title":"Nat. Commun."},{"key":"2353_CR47","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"2353_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"2353_CR49","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"key":"2353_CR50","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","volume":"27","author":"A Liberzon","year":"2011","unstructured":"Liberzon, A. et al. Molecular signatures database (MSigDB) 3.0. Bioinformatics 27, 1739\u20131740 (2011).","journal-title":"Bioinformatics"},{"key":"2353_CR51","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1186\/s12859-022-05005-1","volume":"23","author":"C Wieder","year":"2022","unstructured":"Wieder, C., Lai, R. P. J. & Ebbels, T. M. D. Single sample pathway analysis in metabolomics: performance evaluation and application. BMC Bioinformatics 23, 481 (2022).","journal-title":"BMC Bioinformatics"}],"updated-by":[{"DOI":"10.1038\/s41590-026-02438-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000}}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02353-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02353-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02353-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T08:02:44Z","timestamp":1769241764000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02353-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["2353"],"URL":"https:\/\/doi.org\/10.1038\/s41590-025-02353-x","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"14 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41590-026-02438-1","URL":"https:\/\/doi.org\/10.1038\/s41590-026-02438-1","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors report no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}